Synthesis, docking study, and structure-activity relationship of novel niflumic acid derivatives acting as anticancer agents by inhibiting VEGFR or EGFR tyrosine kinase activities

Yahya Yaseen; Ammar Kubba; Wurood Shihab; Lubna Tahtamouni

doi:10.3897/pharmacia.69.e86504

Research Article

Pharmacia 69(3): 595-614
https://doi.org/10.3897/pharmacia.69.e86504 (05 Jul 2022)

Other versions:

(5)

(0)

Omeed M. Hassan, Ammar Kubba, Lubna H. Tahtamouni (2023)
Novel 5-bromoindole-2-carboxylic Acid Derivatives as EGFR Inhibitors: Synthesis, Docking Study, and Structure Activity Relationship. Anti-Cancer Agents in Medicinal Chemistry 23: 1336.

DOI: 10.2174/1871520623666230227153449

Shaker A. Abdul Hussein, Ammar A. Razzak Mahmood, Lubna H. Tahtamouni, Asim A. Balakit, Yahya S. Yaseen, Rehab A. Al‐Hasani (2023)
New Combretastatin Analogs as Anticancer Agents: Design, Synthesis, Microtubules Polymerization Inhibition, and Molecular Docking Studies. Chemistry & Biodiversity 20: .

DOI: 10.1002/cbdv.202201206

Yahya S. Yaseen, Ammar A.R. Mahmood, Ali H. Abbas, Wurood A. Shihab, Lubna H. Tahtamouni (2023)
New Niflumic Acid Derivatives as EGFR Inhibitors: Design, Synthesis, In silico Studies, and Anti-proliferative Assessment. Medicinal Chemistry 19: 445.

DOI: 10.2174/1573406419666221219144804

Thamer Alorini, Ahmed N. Al-Hakimi, Ismail Daoud, Fahad Alminderej, Abuzar E. A. E. Albadri, Lotfi Aroua (2023)
Synthesis, characterization, anticancer activity and molecular docking of metal complexes bearing a new Schiff base ligand. Journal of Biomolecular Structure and Dynamics : 1.

DOI: 10.1080/07391102.2023.2191725

Omeed M. Hassan, Ammar A. Razzak Mahmood, Ali H. Hamzah, Lubna H. Tahtamouni (2022)
Design, Synthesis, and Molecular Docking Studies of 5‐Bromoindole‐2‐Carboxylic Acid Hydrazone Derivatives: In Vitro Anticancer and VEGFR‐2 Inhibitory Effects. ChemistrySelect 7: .

DOI: 10.1002/slct.202203726

This website uses cookies in order to improve your web experience. Read our Cookies Policy